Myocardial Infarction
Showing NaN - NaN of 28
Myocardial Infarction Trial in Worldwide (Empagliflozin, Placebo)
Recruiting
- Myocardial Infarction
- Empagliflozin
- Placebo
-
Alexander City, Alabama
- +464 more
Aug 22, 2022
Vascular Events In Patients Undergoing Same-day Noncardiac
Recruiting
- Preoperative Care
- +2 more
-
Montreal, Quebec, Canada
- +1 more
Jul 28, 2022
Myocardial Infarction, Anemia Trial in Worldwide (Red Blood Cell Transfusion)
Recruiting
- Myocardial Infarction
- Anemia
- Red Blood Cell Transfusion
-
Little Rock, Arkansas
- +131 more
May 3, 2022
Heart Failure, Myocardial Infarction Trial in Canada, Puerto Rico, United States (High Dose Trivalent Influenza Vaccine,
Completed
- Heart Failure
- Myocardial Infarction
- High Dose Trivalent Influenza Vaccine
- Standard Dose Quadrivalent Influenza Vaccine
-
Birmingham, Alabama
- +189 more
Dec 22, 2021
Direct Oral Anticoagulants in Atrial Fibrillation
Completed
- Atrial Fibrillation
- +5 more
- Direct oral anticoagulants (DOACs)
- Warfarin
-
Montréal, Quebec, CanadaCentre de recherche du Centre Hospitalier de l'Université de Mon
Jan 6, 2021
Direct Oral Anticoagulants in Atrial Fibrillation
Completed
- Atrial Fibrillation
- +5 more
- Apixaban (ATC B01AF02)
- +2 more
-
Montréal, Quebec, CanadaCentre de recherche du Centre Hospitalier de l'Université de Mon
Jan 6, 2021
Angina Pectoris, Angina, Unstable, Myocardial Infarction Trial in Canada, United States (Near Infrared Spectroscopy (NIRS)
Completed
- Angina Pectoris
- +2 more
- Near Infrared Spectroscopy (NIRS) Imaging
- intravascular ultrasound (IVUS)
-
Boston, Massachusetts
- +5 more
Dec 10, 2020
Coronary Artery Disease, Myocardial Infarction Trial in Montreal (colchicine, colchicine )
Completed
- Coronary Artery Disease
- Myocardial Infarction
- colchicine
- colchicine placebo
-
Montreal, Quebec, CanadaMontreal Heart Institute
Sep 23, 2020
Sodium-glucose Cotransporter 2 Inhibitors and Risk of
Completed
- Type2 Diabetes
- +5 more
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors
- Dipeptidyl peptidase-4 (DPP-4) inhibitors
-
Montreal, Quebec, CanadaLady Davis Institute for Medical Research, Jewish General Hospit
Oct 1, 2020
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Myocardial Infarction, Heart Failure, Coronary Artery Disease Trial in Montreal (Secondary prevention and cardiac rehabilitation
Completed
- Myocardial Infarction
- +2 more
- Secondary prevention and cardiac rehabilitation clinic
-
Montreal, Quebec, CanadaCentre for preventive medicine and physical activity of the Mont
Oct 17, 2018
Myocardial Infarction Trial in Canada (tenecteplase, enoxaparin, clopidogrel)
Completed
- Myocardial Infarction
- tenecteplase
- +3 more
-
Edmonton, Alberta, Canada
- +15 more
May 18, 2017
Myocardial Infarction Trial in Worldwide (Percutaneous Coronary Intervention (PCI), RO4905417, )
Completed
- Myocardial Infarction
- Percutaneous Coronary Intervention (PCI)
- +2 more
-
Huntsville, Alabama
- +65 more
Nov 1, 2016
Myocardial Infarction, Sudden Death Trial in Worldwide (Implantable Cardioverter Defibrillator + Usual Care, Usual care)
Unknown status
- Myocardial Infarction
- Sudden Death
- Implantable Cardioverter Defibrillator + Usual Care
- Usual care
-
Huntsville, Alabama
- +93 more
Jul 7, 2016
Cardiovascular Diseases, Heart Diseases, Cerebrovascular Accident Trial in Canada, United States (Extended release niacin,
Terminated
- Cardiovascular Diseases
- +5 more
- Extended release niacin
- Simvastatin
-
Birmingham, Alabama
- +90 more
Mar 8, 2016
Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor
Completed
- Myocardial Infarction
- +3 more
- Ticagrelor 90 mg
- +2 more
-
Alexander City, Alabama
- +846 more
Dec 18, 2015
Acute Coronary Syndrome, Myocardial Infarction, Smoking Trial in Worldwide (Bupropion HCl ER, Placebo)
Completed
- Acute Coronary Syndrome
- +2 more
- Bupropion HCl ER
- Placebo
-
Pueblo, Colorado
- +37 more
Apr 10, 2015
Acute Coronary Syndrome, Myocardial Infarction, Myocardial Ischemia Trial in Worldwide (Rivaroxaban 2.5 mg, Rivaroxaban 5 mg,
Completed
- Acute Coronary Syndrome
- +3 more
- Rivaroxaban 2.5 mg
- +3 more
-
Birmingham, Alabama
- +583 more
Aug 26, 2014
Myocardial Infarction Trial in Worldwide (abciximab ; reteplase , abciximab, abciximab, Abciximab; reteplase; abciximab ;
Completed
- Myocardial Infarction
- abciximab placebo; reteplase placebo, abciximab, abciximab
- +2 more
-
Phoenix, Arizona
- +234 more
Jul 25, 2014
Myocardial Infarction, Heart Failure, Heart Enlargement Trial in Canada, Poland, United States (PG-116800 (given as PG-530742),
Completed
- Myocardial Infarction
- +2 more
- PG-116800 (given as PG-530742)
- Placebo tablet
-
Little Rock, Arkansas
- +51 more
Sep 27, 2011
Myocardial Infarction Trial in Canada, United States (, PRT060128 Potassium)
Terminated
- Myocardial Infarction
- placebo
- PRT060128 Potassium
-
Tallahassee, Florida
- +30 more
Dec 28, 2010